Kestra Medical Technologies Inc
NASDAQ:KMTS
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| US |
K
|
Kestra Medical Technologies Inc
NASDAQ:KMTS
|
1.4B USD |
Loading...
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
201.9B USD |
Loading...
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
178.4B USD |
Loading...
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
148B USD |
Loading...
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
125B USD |
Loading...
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
113.6B USD |
Loading...
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
47.8B EUR |
Loading...
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
52.6B USD |
Loading...
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
50.3B USD |
Loading...
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
50.3B USD |
Loading...
|
|
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
38.3B USD |
Loading...
|
Market Distribution
| Min | -24 813% |
| 30th Percentile | 28.9% |
| Median | 43% |
| 70th Percentile | 60.5% |
| Max | 10 905 714.3% |
Other Profitability Ratios
Kestra Medical Technologies Inc
Glance View
Kestra Medical Technologies Ltd. operates as a commercial-stage, wearable medical device and digital healthcare company. The company is headquartered in Kirkland, Washington. The company went IPO on 2025-03-06. The firm is focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies. The company has developed and commercializing its Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. Its Cardiac Recovery System platform include the ASSURE WCD, a next generation wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA). The ASSURE WCD automatically monitors elevated risk patients and, if needed, delivers a defibrillation shock to return the patient’s heart to normal rhythm. In addition to the ASSURE WCD, its Cardiac Recovery System platform includes a comprehensive suite of fully integrated digital solutions and services.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for Kestra Medical Technologies Inc is 46.4%, which is above its 3-year median of 37.9%.
Over the last 1 years, Kestra Medical Technologies Inc’s Gross Margin has increased from 24.9% to 46.4%. During this period, it reached a low of 24.9% on Oct 1, 2024 and a high of 46.4% on Dec 1, 2025.
